How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,349 results for

Coronary Risk Stratification of Chest Pain

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

41. Comparison of early biomarker strategies with the Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for risk stratification of emergency department patients with chest pain. (Abstract)

Comparison of early biomarker strategies with the Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for risk stratification of emergency department patients with chest pain. To compare cardiac risk stratification using a 0 and 2 h point-of-care (POC) cardiac troponin (cTn), 0 and 2 h POC multi-biomarkers against the 0 and 6 h laboratory cTn reference standard.A prospective observational study of ED patients presenting with chest pain was performed. Patients (...) were risk stratified and treated as per the Heart Foundation of Australia/Cardiac Society of Australia and New Zealand (HF-A/CS-ANZ) guidelines using the 0 and 6 h laboratory cTn (T6). Patients were further stratified using a 0 and 2 h POC cTn (T2) plus 0 and 2 h POC multi-biomarkers (cTn, creatine kinase-MB, myoglobin) (M2). The T6, T2 and M2 strategies were compared using the 30-day major adverse cardiac events as the primary outcome.Seven hundred and four patients (median age 54 years, male 62.1

2012 Emergency medicine Australasia

42. REACTED - Reducing Acute Chest pain Time in the ED: A prospective pre-/post-interventional cohort study, stratifying risk using early cardiac multi-markers, probably increases discharges safely. (Abstract)

REACTED - Reducing Acute Chest pain Time in the ED: A prospective pre-/post-interventional cohort study, stratifying risk using early cardiac multi-markers, probably increases discharges safely. ED chest pain assessments can be challenging, lengthy and contribute to overcrowding. Rapid accurate risk stratification strategies should improve ED length of stay (EDLOS). Emergency, Biochemistry and Cardiology implemented new guidelines using paired (<3 h) multiple cardiac markers to stratify (...) patients. The intervention would reduce chest pain EDLOS. We observed for safety and disposition effects.This is a single-site, prospective observational, before and after intervention study. In December 2009, paired multiple cardiac markers, the second at least 4 h from pain, replaced late troponins. The 4 h rule (ED flow improvement) started in April 2009 (unplanned confounder). Demographics, clinical features, risk assessment and disposition; preferably prospective. Administrative datasets provided

2016 Emergency medicine Australasia

43. Coronary Risk Stratification of Chest Pain

Coronary Risk Stratification of Chest Pain Coronary Risk Stratification of Chest Pain Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 (...) Coronary Risk Stratification of Chest Pain Coronary Risk Stratification of Chest Pain Aka: Coronary Risk Stratification of Chest Pain , Likelihood of Coronary Disease as Cause of Chest Pain , Chest Pain Prediction Rules , Chest Pain Decision Rules From Related Chapters II. Risk Factors See s See III. Diagnosis: Prediction Rules IV. Criteria: High Likelihood Known history Typical l symptoms Men over age 60 Women over age 70 Characteristic symptoms radiating to the right arm or (LR+ 4.7) radiating

2015 FP Notebook

44. Improving risk stratification in patients with chest pain: the Erlanger HEARTS(3) score. (Abstract)

Improving risk stratification in patients with chest pain: the Erlanger HEARTS(3) score. The HEART score uses elements from patient History, Electrocardiogram, Age, Risk Factors, and Troponin to obtain a risk score on a 0- to 10-point scale for predicting acute coronary syndromes (ACS). This investigation seeks to improve on the HEART score by proposing the HEARTS(3) score, which uses likelihood ratio analysis to give appropriate weight to the individual elements of the HEART score as well (...) interval difference in areas, 0.064-0.110).The HEARTS(3) score reliably risk stratifies patients with chest pain for 30-day ACS. Prospective studies need to be performed to determine if implementation of this score as a decision support tool can guide treatment and disposition decisions in the management of patients with chest pain.Copyright © 2012 Elsevier Inc. All rights reserved.

2012 American Journal of Emergency Medicine

45. Biomarkers, Blood Pressure, BIS: Risk Stratification/Management of Patients at Cardiac Risk in Major Noncardiac Surgery

Update Posted: September 12, 2018 Last Verified: September 2018 Keywords provided by Miodrag Filipovic, Prof. Dr. med., Cantonal Hospital of St. Gallen: Intraoperative blood pressure Triple low Anesthetic overdose Major adverse cardiac events (MACE) Myocardial injury after noncardiac surgery (MINS) Perioperative risk stratification Brain-type natriuretic peptide (BNP) High-sensitivity cardiac Troponin I (hs-cTnI) Additional relevant MeSH terms: Layout table for MeSH terms Heart Failure Acute Coronary (...) Biomarkers, Blood Pressure, BIS: Risk Stratification/Management of Patients at Cardiac Risk in Major Noncardiac Surgery Biomarkers, Blood Pressure, BIS: Risk Stratification/Management of Patients at Cardiac Risk in Major Noncardiac Surgery - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum

2015 Clinical Trials

46. Robot-assisted surgery in thoracic and visceral indications

and visceral surgery. Thoracic surgery is concerned with conditions of the lungs, chest wall and diaphragm and is generally dominated by treatment of malignant disease. Thoracic procedures that were exam- ined in the review included, in accordance with the project plan, pulmonary lobectomy, lung seg- mentectomy and mediastinal surgery. Visceral surgery deals with all aspects of the surgical treat- ment of benign and malignant diseases of abdominal organs, the entire gastrointestinal tract, en- docrine (...) events in studies that used the Clavien-Dindo classification 72 Table 7: Summary of findings regarding safety for thoracic and visceral indications 74 Table A1: Overview of guidelines with specific recommendations regarding robot-assisted surgery 96 Table A2: Characteristics & risk of bias of randomised controlled studies 97 Table A3: Characteristics & risk of bias of non-randomised studies 134 Table A4: Summary table characterising the applicability of a body of studies 152 Figures Figure 1: Flow

2019 EUnetHTA

47. Epicardial Fat Volume Improves the Prediction of Obstructive Coronary Artery Disease Above Traditional Risk Factors and Coronary Calcium Score. Full Text available with Trip Pro

reclassification improvement and integrated discrimination improvement, excellent area under the receiver operating characteristic curve and favorable calibration. Further, the new model demonstrated a better prediction of clinical outcome, resulting in a more cost-effective risk stratification to optimize decision-making of downstream diagnosis and treatment.Addition of EFV to conventional risk factors and coronary calcium score offered a more accurate and effective estimation for pretest probability (...) of obstructive coronary artery disease, which may help to improve initial management of stable chest pain.

2019 Circulation. Cardiovascular imaging

48. Coronary Atherosclerosis Disease Early Identification and Risk Stratification by Noninvasive Imaging

. myocardial infarction was defined based on the criteria of typical chest pain, elevated cardiac enzyme levels and typical alterations of the electrocardiogram. ) Biospecimen Retention: Samples Without DNA bio-markers of coronary artery disease Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study (...) Coronary Atherosclerosis Disease Early Identification and Risk Stratification by Noninvasive Imaging Coronary Atherosclerosis Disease Early Identification and Risk Stratification by Noninvasive Imaging - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please

2016 Clinical Trials

49. Risk stratification with exercise N13-ammonia PET in adults with anomalous right coronary arteries Full Text available with Trip Pro

Risk stratification with exercise N13-ammonia PET in adults with anomalous right coronary arteries In adults with an interarterial and intramural course of an anomalous right coronary artery from the left sinus (AAORCA), surgical unroofing is recommended in the setting of myocardial ischaemia. However, data regarding functional testing are limited, and the management of adults without ischaemia is unclear. To evaluate these patients, we employed an exercise N(13)-ammonia positron emission (...) tomography (PET) protocol. We hypothesised that patients with typical angina and exertional dyspnoea would be more likely to have ischaemia and that patients without ischaemia could be managed conservatively.Between July 2008 and December 2014, we retrospectively identified 27 consecutive patients >18 years old with an interarterial and intramural course of an AAORCA who had exercise N(13)-ammonia PET.The majority of patients had anatomic delineation with cardiac CT (25, 93%), and most patients had chest

2016 Open heart

50. Stress-Delta Biomarkers for Acute Coronary Syndrome Risk Stratification

Stress-Delta Biomarkers for Acute Coronary Syndrome Risk Stratification Stress-Delta Biomarkers for Acute Coronary Syndrome Risk Stratification - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Stress-Delta (...) Biomarkers for Acute Coronary Syndrome Risk Stratification The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02717702 Recruitment Status : Active, not recruiting First Posted : March 24, 2016 Last Update Posted : July 31, 2018 Sponsor: Duke University Information provided by (Responsible Party): Duke

2016 Clinical Trials

51. A 0-Hour/1-Hour Protocol for Safe, Early Discharge of Chest Pain Patients Full Text available with Trip Pro

A 0-Hour/1-Hour Protocol for Safe, Early Discharge of Chest Pain Patients Guidelines recommend a 0-hour/1-hour high-sensitivity cardiac troponin T (hs-cTnT) diagnostic strategy in acute chest pain patients. There are, however, little data on the performance of this strategy when combined with clinical risk stratification. We aimed to evaluate the diagnostic accuracy of an accelerated diagnostic protocol (ADP) using the 0-hour/1-hour hs-cTnT strategy together with an adapted Thrombolysis (...) two patients with UA and no patients with AMI or other forms of MACE.An ADP using the guideline recommended 0-hour/1-hour hs-cTnT strategy rapidly identified patients with a very low risk of 30-day MACE including UA where no further cardiac testing would be needed. This could potentially allow safe early discharge of about 40% of ED chest pain patients.© 2017 by the Society for Academic Emergency Medicine.

2017 EvidenceUpdates

52. Standards for Studies of Neurological Prognostication in Comatose Survivors of Cardiac Arrest: A Scientific Statement From the American Heart Association

cardiac arrest care. First, families or surrogate decision-makers must develop realistic expectations and make plans about ongoing intensive care. Second, prognosis determines the extent to which resources are mobilized or withheld for individual patients; indeed, WLST remains the most common cause of in-hospital death for patients resuscitated from both IHCA and OHCA. Third, prognostic tests can potentially be used for early risk stratification to identify the most appropriate population for clinical (...) Standards for Studies of Neurological Prognostication in Comatose Survivors of Cardiac Arrest: A Scientific Statement From the American Heart Association Standards for Studies of Neurological Prognostication in Comatose Survivors of Cardiac Arrest: A Scientific Statement From the American Heart Association | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search December 2019 November 2019 October 2019 September 2019 August 2019 July 2019 June 2019 May

2019 American Heart Association

53. Cardiac Imaging in Low-Risk and Asymptomatic Patients

, 2015. The summary of findings was prepared from the abstracts of the relevant information. Please note that data contained in abstracts may not always be an accurate reflection of the data contained within the full article. SELECTION CRITERIA One reviewer screened citations and selected studies based on the inclusion criteria presented in Table 1. Cardiac Imaging in Low Risk Patients 2 Table 1: Selection Criteria Population Inpatients or outpatients: Q1: Low risk for coronary heart disease (...) . The health technology assessment by the Agency for Healthcare Research and Quality (AHRQ) 1 examined the gold standard tests for the diagnosis of coronary artery disease (CAD) and/or acute coronary syndrome (ACS) (with or without chest pain) in patients at low to intermediate risk. AHRQ reported that among low-risk patients who are not referred for coronary angiography but who undergo clinical observation and non-invasive testing, several noninvasive tests have served as acceptable reference standards

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

54. Risk Stratification for Coronary Artery Disease With Type 2 Diabetic Patients

Risk Stratification for Coronary Artery Disease With Type 2 Diabetic Patients Risk Stratification for Coronary Artery Disease With Type 2 Diabetic Patients - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . Risk Stratification for Coronary Artery Disease With Type 2 Diabetic Patients (CAD-risk) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02494557 Recruitment Status : Completed First Posted : July 10, 2015 Last Update Posted : May 23, 2017 Sponsor: Acarix Collaborators: Steno Diabetes Center

2015 Clinical Trials

55. Dilated Thoracic Esophagus Presenting with Painful Progressive Persistent Dysphagia and Leukocytosis of Unknown Origin Full Text available with Trip Pro

segment dilatation of the upper and mid-thoracic esophagus with generalized circumferential thickening of the distal esophagus. He was empirically on cefazolin and metronidazole but later switched to piperacillin, tazobactam, and fluconazole. Cardiac risk stratification was done for an esophagogastroduodenoscopy. However, the patient and the family opted for palliative care and agreed to a do-not-resuscitate/do-not-intubate status. In esophageal cancers, tumor-related leukocytosis and neutrophilia (...) vomiting for several days. He denied fever, diarrhea, hoarseness of voice, change in bowel movement, hematemesis, hematochezia, melena, orthopnea, dyspnea at rest, palpitation, and abdominal pain. A chest x-ray (lateral view) showed debris in a dilated thoracic esophagus with fluid. An esophagogram showed a 10 x 3 cm obstructive mass with irregular mucosa within the proximal esophagus from the thoracic vertebra levels four to ten. A computed tomography scan of the chest with contrast showed long

2017 Cureus

56. Exploratory examination of the need for revision of the DMP "coronary heart disease"

between the need for oxygen and the oxygen supply in the heart muscle and subsequently to myocardial ischaemia. This commonly manifests itself as angina pectoris (AP), that is, sudden pain in the chest, jaw, arm or other regions, lasting seconds to minutes [9]. The development of heart failure, myocardial infarction, or sudden cardiac death may be consequences of CHD [10]. CHD is a chronic disease. Stable AP is a clinical form of manifestation of CHD that reproducibly occurs under physical or mental (...) stress and is constant over months. In contrast, acute phases of CHD that are directly life-threatening or fatal are summarized under the term “acute coronary syndrome”. This also includes unstable AP occurring under slight or no physical activity, myocardial infarction with or without ST-segment elevations, as well as sudden cardiac death [11,12]. Risk factors for the development of CHD include increasing age, male sex, smoking, obesity, hypertension, hypercholesterolaemia, and diabetes mellitus

2017 Institute for Quality and Efficiency in Healthcare (IQWiG)

57. The Role of Cardiac MRI in Patients with Troponin-Positive Chest Pain and Unobstructed Coronary Arteries Full Text available with Trip Pro

The Role of Cardiac MRI in Patients with Troponin-Positive Chest Pain and Unobstructed Coronary Arteries Acute coronary syndrome (ACS) still remains one of the leading causes of mortality and morbidity worldwide. Seven to fifteen percent of patients presenting with ACS have unobstructed coronary artery disease (CAD) on urgent angiography. Patients with ACS and unobstructed coronary arteries represent a clinical dilemma and their diagnosis and management is quite variable in current practice (...) on the diagnostic role of cardiac magnetic resonance (CMR) in patients with ACS and unobstructed coronary arteries. We have also highlighted the potential role of CMR as a risk stratification or prognostication tool for this patient population.

2015 Current cardiovascular imaging reports

58. CCS guidelines on perioperative cardiac risk assessment and management for patients undergoing noncardiac surgery Full Text available with Trip Pro

: August 4, 2016 ; | Figure 1 Preoperative risk assessment and postoperative monitoring flow diagram. BNP, brain natriuretic peptide; ECG, electrocardiogram; NT-proBNP, N-terminal pro-brain natriuretic peptide; PACU, postanesthesia care unit; PHTN, pulmonary hypertension; RCRI, Revised Cardiac Risk Index. ∗ Significant cardiovascular disease includes known history of coronary artery disease, cerebral vascular disease, peripheral artery disease, congestive heart failure, severe PHTN or a severe (...) approach) and inform decisions around monitoring (eg, troponin measurements) after surgery. Which Patients Should Undergo Cardiac Risk Assessment Before Noncardiac Surgery? Our recommendations only pertain to patients (1) 45 years of age and older or (2) patients 18-44 years of age with known significant cardiovascular disease (ie, coronary artery disease, cerebral vascular disease, peripheral arterial disease, congestive heart failure, severe pulmonary hypertension, or a severe obstructive

2016 Canadian Cardiovascular Society

59. Suspected Thoracic Aortic Aneurysm

aortic aneurysm. J Med Assoc Thai. 2010;93(9):1050-1057. 32. Kopp AF, Kuttner A, Trabold T, Heuschmid M, Schroder S, Claussen CD. Multislice CT in cardiac and coronary angiography. Br J Radiol. 2004;77 Spec No 1:S87-97. 33. Schlosser FJ, Mojibian HR, Dardik A, Verhagen HJ, Moll FL, Muhs BE. Simultaneous sizing and preoperative risk stratification for thoracic endovascular aneurysm repair: role of gated computed tomography. J Vasc Surg. 2008;48(3):561-570. 34. Shin HJ, Kim SS, Lee JH, et al (...) Criteria ® “Thoracic Aorta Interventional Planning and Follow-up” [5]. Limitations of CTA include streak artifact from implanted devices, variable quality of images through the aortic root and coronary vessels due to cardiac motion in non-gated studies, and the need for IV iodinated contrast [32-34]. Electrocardiogram (ECG)-gated CTA is often used to minimize cardiac motion artifact and to allow for accurate orthogonal measurement of the ascending thoracic aorta [35,36]. ACR Appropriateness Criteria ®

2017 American College of Radiology

60. GDF-15 predicts cardiovascular events in acute chest pain patients. Full Text available with Trip Pro

GDF-15 predicts cardiovascular events in acute chest pain patients. Treatment of patients presenting with possible acute myocardial infarction (AMI) is based on timely diagnosis and proper risk stratification aided by biomarkers. We aimed at evaluating the predictive value of GDF-15 in patients presenting with symptoms suggestive of AMI.Consecutive patients presenting with suspected AMI were enrolled in three study centers. Cardiovascular events were assessed during a follow-up period of 6 (...) presenting with suspected MI. GDF-15 levels correlate with the severity of CAD and can identify and risk-stratify patients who need coronary revascularization.

2017 PLoS ONE

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>